Individualising use of aspirin to prevent pre‐eclampsia: a framework for clinical decision making

No abstract is available for this paper.

• Publication year

  2003

• Venue

  BJOG: an International Journal of Obstetrics and Gynaecology

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1471-0528.2003.03002.xPMID 14550356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiplatelet agents for preventing and treating pre-eclampsia.

  2007cited by this paper
• Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.

  2004cited by this paper
• Re: Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation.

  2003cited by this paper
• Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review

  2002cited by this paper
• Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses.

  2002cited by this paper
• Assessment of therapeutic safety in systematic reviews: literature review

  2001cited by this paper
• The Advanced Handbook of Methods in Evidence Based Healthcare

  2001cited by this paper
• Results of clinical trials and systematic reviews: To whom do they apply?

  2001cited by this paper
• Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review

  2001cited by this paper
• Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study

  2001cited by this paper
• Users ’ Guides to the Medical Literature

  2000cited by this paper
• Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. Evidence-Based Medicine Working Group.

  2000cited by this paper
• How useful is uterine artery Doppler flow velocimetry in the prediction of pre‐eclampsia, intrauterine growth retardation and perinatal death? An overview

  2000cited by this paper
• A prospective management study of slow‐release aspirin in the palliation of uteroplacental insufficiency predicted by uterine artery Doppler at 20 weeks

  2000cited by this paper
• Numbers needed to treat derived from meta-analyses—sometimes informative, usually misleading

  1999cited by this paper
• An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials.

  1998cited by this paper
• Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm.

  1998cited by this paper
• Investigating underlying risk as a source of heterogeneity in meta-analysis.

  1997cited by this paper
• Meta-analysis: Beyond the grand mean?

  1997cited by this paper
• The relation between treatment benefit and underlying risk in meta-analysis

  1996cited by this paper
• Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations

  1995cited by this paper
• The number needed to treat: a clinically useful measure of treatment effect

  1995cited by this paper
• An evidence based approach to individualising treatment

  1995cited by this paper
• Risks and benefits of treating mild hypertension: a misleading meta-analysis?

  1995cited by this paper
• Can overall results of clinical trials be applied to all patients?

  1995cited by this paper
• Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group.

  1995cited by this paper
• Can overall results of clinical trials be applied to all patients

  1995cited by this paper
• Generalizing the results of randomized clinical trials.

  1994cited by this paper
• Who benefits from medical interventions?

  1994cited by this paper
• Cholesterol lowering and mortality: the importance of considering initial level of risk.

  1993cited by this paper
• A Consumer's Guide to Subgroup Analyses

  1992cited by this paper
• Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean

  1992cited by this paper
• Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

  1991cited by this paper
• Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986.

  1990cited by this paper
• Large trials with simple protocols: indications and contraindications.

  1989cited by this paper
• The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects

  1989cited by this paper
• Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age.

  1988cited by this paper
• Aspirin and congenital malformations.

  1976cited by this paper
• THE AMERICAN AND HIS DIET.

  1964cited by this paper

• Use of Machine Learning to Estimate the Per-Protocol Effect of Low-Dose Aspirin on Pregnancy Outcomes

  2022cites this paper
• Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2021cites this paper
• A description of the methods of the aspirin supplementation for pregnancy indicated risk reduction in nulliparas (ASPIRIN) study

  2017cites this paper
• Niveles séricos de nitritos-nitratos en embarazadas con hipertensión gestacional y en pacientes con embarazos no complicados

  2012cites this paper
• Fetal and neonatal effects of anticoagulants used in pregnancy: a review.

  2012cites this paper
• Prediction and prevention of fetal growth restriction and compromise of fetal wellbeing : systematic reviews and meta-analyses with model based economic evaluation

  2011cites this paper
• How to interpret randomised trials of test–treatment combinations: a critical evaluation of research on uterine Doppler test to predict, and aspirin to prevent, pre‐eclampsia

  2010cites this paper
• Transabdominal uterine artery Doppler between 11 and 14 weeks of gestation for the prediction of outcome in high-risk pregnancies

  2008cites this paper
• Clinical inquiries. Does low-dose aspirin reduce preeclampsia and other maternal-fetal complications?

  2008cites this paper
• Tests for predicting complications of pre-eclampsia: A protocol for systematic reviews

  2008cites this paper
• A 30-year-old woman with chronic hypertension trying to conceive.

  2007cites this paper
• Anticoagulants in Pregnancy

  2006cites this paper
• Subclinical signs of vascular damage relate to enhanced platelet responsiveness among nonpregnant formerly preeclamptic women.

  2006cites this paper
• Progesterone for the prevention of preterm birth: a critical evaluation of evidence.

  2006cites this paper
• Pre-eclampsia

  2005cites this paper
• Gerard W. Ostheimer “What’s New in Obstetric Anesthesia” Lecture

  2005cites this paper
• Gerard W. Ostheimer "What's New in Obstetric Anesthesia"

  2005cites this paper
• Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.

  2005cites this paper
• Early treatment with low-dose aspirin is effective for the prevention of preeclampsia and related complications in high-risk patients selected by the analysis of their historic risk factors.

  2005cites this paper
• Progestational Agents to Prevent Preterm Birth: A Meta-Analysis of Randomized Controlled Trials

  2005cites this paper
• Clinical Use of Non-Steroidal Anti-Inflammatory Drugs

  2004cites this paper
• A systematic review of training in acute obstetric emergencies

  2004influential citation
• Modernmanagement of placenta previa Related review: Recent advances in the management of placenta previa (pp. 447–451)

  2004cites this paper
• Individualising use of aspirin to prevent pre‐eclampsia: a framework for clinical decision making

  2004influential citation